Chiudi ricerca

07 September 2026 | Corporate, Intranet

Pharmanutra in MotoGP: agreement with Enea Bastianini, new Cetilar® ambassador

The Italian KTM Tech3 Racing rider becomes ambassador for Cetilar® and Cetilar® Nutrition, reinforcing the Group’s presence in international motorsport and the 2026 MotoGP World Championship

Pharmanutra announces a new sports partnership with Enea Bastianini, rider for Red Bull KTM Tech3 competing in the MotoGP World Championship and one of the leading figures in international motorcycle racing.

Moto2 World Champion in 2020 and a prominent competitor in recent MotoGP seasons, Bastianini officially joins the Cetilar® universe as a brand ambassador.

The agreement further strengthens the Group’s strategy in professional sport, with a specific focus on musculoskeletal wellbeing, advanced sports nutrition, scientific research, and performance support – areas that are particularly relevant in a discipline as physically and mentally demanding as MotoGP.

Cetilar® and MotoGP: a performance-driven partnership

Born in Rimini in 1997, Enea Bastianini is one of the most talented and respected Italian riders on the international motorcycle racing scene. After winning the Moto2 World Championship in 2020 and setting the record for podium finishes in Moto3, he established himself among MotoGP’s leading riders, finishing third in the 2022 World Championship and ranking as the highest-placed independent rider of the season.

Currently competing in MotoGP with Red Bull KTM Tech3, Bastianini is preparing for the second half of the 2026 season, which resumes with the Red Bull Grand Prix of San Marino and the Rimini Riviera at Misano circuit, one of the most iconic events on the MotoGP calendar.

Against this backdrop, the partnership with Pharmanutra is built on shared values: preparation, determination, continuous improvement, and attention to every detail that can contribute to performance.

Research, innovation and direct athlete feedback

The partnership involves the entire Cetilar® ecosystem, the brand developed by Pharmanutra to support musculoskeletal wellbeing and athletic performance.

Bastianini will serve as ambassador for both the Cetilar® line – solutions based on Cetylated Fatty Acids (CFAs) designed to support muscles and joints – and Cetilar® Nutrition, the advanced sports nutrition line launched in 2023 to support energy, endurance, recovery, and performance in high-intensity sports.

The collaboration will also foster ongoing direct interaction between the company and the athlete, generating valuable feedback to support the continuous development and optimisation of product formulations.

Roberto Lacorte, Vice Chairman and CEO of Pharmanutra S.p.A., comments: “There is a very strong affinity with Enea Bastianini, based first and foremost on our shared passion for sport and the constant pursuit of competitive performance. Enea is a dedicated athlete of great calibre, who never settles and leaves nothing to chance, making him the perfect ambassador for a company like ours, built on research, innovation and continuous improvement. Direct interaction with athletes is fundamental to Pharmanutra and provides the basis for the development and refinement of our formulations. We are therefore delighted to be able to count on the contribution of a champion like Bastianini in such a prestigious setting as MotoGP.”

Enea Bastianini comments: “The biggest challenges are faced with the right people by your side. That’s why I’m happy to begin this journey with Cetilar® and Pharmanutra, a company that has built its success through commitment, innovation and a strong sporting culture.”

A new milestone in Pharmanutra’s international sports partnership strategy

With Enea Bastianini joining the Cetilar® family, Pharmanutra continues to strengthen its presence across major international sporting arenas, partnering with athletes who embody commitment, determination, and the pursuit of excellence.

Through continuous dialogue with elite athletes, the Group further reinforces its commitment to innovation and strengthens its position as a reference point in musculoskeletal wellbeing, advanced sports nutrition, and performance support.

Logo PHN